BAT offers to make nicotine pouches in Germany if rules and taxes change
BAT signals readiness to produce nicotine pouches in Germany, citing widespread smuggling, an estimated €500m tax loss and the need for stable regulation.
Germany sees potential factory if law shifts
British American Tobacco (BAT) has told German officials it is prepared to manufacture nicotine pouches in Germany if lawmakers provide a predictable regulatory and tax framework. The company’s Germany head, Jorge Araya, framed the proposal as conditional on long-term rules that would protect investor expectations and enable local production of pouches currently sold illegally. BAT’s offer arrives amid a shrinking domestic cigarette industry and concern about unregulated products circulating in the market.
BAT conditions investment on predictable regulation
Araya said BAT would invest in domestic production only where “a moderate, predictable regulatory environment” exists, arguing that firms do not make short-term manufacturing commitments without regulatory clarity. He pointed to BAT’s long presence in Germany and contrasted the firm’s approach with large-scale investments the company is making in other EU markets. BAT’s proposal is explicitly linked to tax and legal changes that would allow legitimate, regulated nicotine pouches to be sold and taxed in Germany.
Illegality, smuggling and the size of the shadow market
Nicotine pouches remain illegal to sell in Germany, yet demand persists. BAT estimates annual consumption at roughly two billion pouches, a volume supplied almost entirely through smuggling or counterfeit production, according to the company. That black market not only evades consumer protections but also circumvents taxation, creating health and fiscal concerns officials say are increasingly hard to ignore.
Estimated fiscal loss and economic stakes
BAT has suggested the German state forfeits around €500 million in tax revenue each year because nicotine pouches are traded outside legal channels. Over five years, the company says, that shortfall could reach approximately €2.5 billion. Producers and trade groups argue that legalising and taxing pouches would both curb illicit trade and create a measurable revenue stream, while opponents warn that legal access could increase youth exposure to nicotine products.
Decline of tobacco manufacturing in Germany
The call for local production comes against a backdrop of decades-long industrial decline. Mid-20th century data show hundreds of tobacco firms and tens of thousands of employees across West Germany; today only a handful of large plants remain. Major manufacturers have consolidated or shifted production to other European countries. Remaining German sites include Japan Tobacco International’s plant in Trier and BAT’s small factory in Bayreuth, while several other facilities have closed or face closure as demand for traditional cigarettes falls.
Political resistance and public-health concerns
Health officials and some state governments remain wary of broadening legal access to novel nicotine products. A recent motion at the federal health minister conference emphasized protecting children and adolescents from products that use trendy designs and sweet flavours to normalise use. Public-health advocates cite reports of adverse effects, including gum damage and nicotine dependence among teenagers, and call for strict limits on flavours, marketing and youth access regardless of taxation or manufacturing plans.
Tax law developments and the EU angle
Germany’s draft tobacco tax law currently does not explicitly cover nicotine pouches, but the federal finance ministry has signalled flexibility if the European Union updates its tobacco tax directive. Officials say national taxation of nicotine pouches could follow an EU-level move to classify and tax such products, opening a legal pathway for regulated sales. Industry representatives point to neighbouring EU markets where pouches are legal and taxed as models for how Germany might structure a domestic regime.
Manufacturing implications and next steps
If Germany shifts its legal and tax approach, BAT and other global companies say they could localise production, reducing reliance on imports from Sweden, Hungary and Italy. Proponents argue this would create jobs, raise tax receipts and bring products under quality controls, while critics caution against normalising nicotine use. Any investment decision, company executives stress, will depend on concrete, long-term commitments from policymakers.
Germany’s choices will shape how the country balances public-health priorities with fiscal and industrial considerations. The debate over nicotine pouches now sits at the intersection of smuggling, taxation and youth protection, and will likely determine whether a new factory opens on German soil.
